Decheng Capital LLC

Q3 2025 13F Holdings

  • Location
    menlo park, CA
  • Num holdings

    23

  • Value ($000)

    $573,196

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0002010850
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
C
CGON

CG ONCOLOGY INC

COM
156944100
$256.65M
45 %

6,371,669

N
NUVB

Nuvation Bio Inc.

COM
67080N101
$96.03M
17 %

25,954,439

---

Upstream Bio Inc.

COM
91678A107
$61.80M
11 %

3,285,293

---

AARDVARK THERAPEUTICS INC

COM
002942100
$52.06M
9 %

3,917,299

---

NEWAMSTERDAM PHARMA CO NV

COM
N62509109
$18.69M
3 %

657,051

---

MERUS NV

COM
N5749R100
$17.56M
3 %

186,546

R
RVMD

REVOLUTION MEDICINES INC(NSM)

COM
76155X100
$9.81M
2 %

210,000

L
LYEL

Lyell Immunopharma, Inc.

COM
55083R104
$9.67M
2 %

595,466

---

BeyondSpring Inc.

SHS
G10830100
$7.76M
1 %

4,286,104

A
ACRS

Aclaris Therapeutics, Inc.

COM
00461U105
$7.68M
1 %

4,041,736

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 23